Recent studies have demonstrated that during fasting, SIRT3-/ mice have diminished fatty acid oxidation, develop a fatty liver, have low levels of ATP production, and show a defect in thermogenesis and hypoglycemia during a cold test [ 22].
Ndst1-deficient mice die after birth and have cerebral hypoplasia, axon guidance errors, defects in the eye and olfactory bulbs, insufficient milk production caused by a defect in lobuloalveolar expansion in the mammary gland, and morphological abnormalities in the podocytes [ 140– 145, 156, 157, 162, 164] 164].
In 1988, Jacob and McDevitt [ 9] reported that NZB/W mice showed diminished production of TNF, a defect stemming from the otherwise healthy NZW parent, and proved that NZB/W disease was at least partly reversible by administration of recombinant TNF early in life.
These observations point to subtle defects in specific antibody production and rule out a defect in the T cell immune response.
T cells from mice lacking STIM1 or its paralogue STIM2 both showed significantly reduced cytokine production in vitro and a defect in regulatory T cell development as well as lympho- and myeloproliferation in vivo.
Some of the treated patients relapsed after the repopulation of B cells, consistent with the model that the breakdown of self-tolerance and the production of autoantibodies reflect a defect in T-cell biology and not a primary B-cell dysfunction.
Shedding of this protein normally occurs upon secondary processing of the MSP1/6/7 complex by PfSUB2 following egress, but as MRT12113 does not directly inhibit PfSUB2 activity (Yeoh et al, 2007) the reduction in MSP183 production must result from a defect in primary processing.
Rogozin claimed during a press conference that "a wavering hand" was possibly responsible for the puncture, and asked: "What is this: a production defect or some premeditated action?" The leak was detected last Wednesday by ground controllers in Houston and Moscow, while the ISS crew was asleep.
In order to consider in-grain defect production, a new mapping methodology is developed to properly normalize in-grain defect production rates for nanocrystalline materials.
Together with the preserved levels of apoB in plasma, these data suggest that a defect in production or secretion of apoB alone cannot explain the change in plasma VLDL.
